switch from semaglutide to retatrutide can i difference between semaglutide and tirzepatide and retatrutide Retatrutide vs Mounjaro (Tirzepatide): Which is Better? Retatrutide vs Semaglutide – Comparison

Let me walk you through what the research actually shows, what I see in practice, and just as importantly where the limits and cautions are

However, while GI risks are outlined on the labels of the drugs, the risk of NAION is not included

Abbreviations IBD: Inflammatory bowel disease GI: Gastrointestinal CD: Crohns disease UC: Ulcerative colitis T2D: Type 2 diabetes CVD: Cardiovascular disease GLP-1 RA: Glucagon-like peptide 1 receptor agonists CVOT: Cardiovascular outcome trial HF: Heart failure NAFLD: Nonalcoholic fatty liver disease HCC: Hepatocellular carcinoma EEC: Enteroendocrine cell GIP: Glucose-dependent insulinotropic polypeptide TNF: Tumor necrosis factor IL: Interleukin JAK: Janus kinase CCL: C-C motif ligand TGF: Tumor growth factor EGF: Epidermal growth factor KGF: Keratinocyte growth factor HGF: Hepatocyte growth factor cAMP: Cyclic adenosine monophosphate NF-kB: Nuclear factor-kB TCA: T cell activation gene SDF: Stromal cellderived factor M-CSF: Macrophage colony stimulating factor CSMC: Colon smooth muscle cell SSM: Stabilized phospholipid micelles DDS: Dextran sodium sulfate DRA: Downregulated in adenoma BLG: Ban-Lan-Gen ACE: Angiotensin-converting enzyme GPBAR: G proteincoupled bile acid receptor iNKT: Invariant natural killer T cells DPP-4: Dipeptidyl peptidase-4 GLP1/2-Fc: GLP1/2-Fc fusion SCID: Severe combined immunodeficiency disease Ex-4: Exendin-4 IRR: Incidence rate ratio BMI: Body mass index APN: Adiponectin MAT: Mesenteric adipose tissue HFD: High-fat diet TLR: Toll-like receptor NASH: Nonalcoholic steatohepatitis HDL: High-density lipoprotein LDL: Low-density lipoprotein CRP: C-reactive protein PPI: Proton pump inhibitor References Papers of particular interest, published recently, have been highlighted as: Of importance Of major importance Satsangi J, Silverberg MS, Vermeire S, Colombel JF

A 2024 meta analysis of clinical trials concluded that 2.4mg semaglutide produces sustained weight loss that is well tolerated and safe. That said, there is a recognized semaglutide weight loss plateau